Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
Science (2021) Vol. 372, Iss. 6549, pp. 1413-1418
Open Access | Times Cited: 573

Showing 1-25 of 573 citing articles:

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1106
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 654-656
Open Access | Times Cited: 1078
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
Science (2022) Vol. 376, Iss. 6593
Open Access | Times Cited: 838
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern
Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, et al.
Science (2021) Vol. 374, Iss. 6572
Open Access | Times Cited: 782
SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
Alison Tarke, Camila H. Coelho, Zeli Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 847-859.e11
Open Access | Times Cited: 760
Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman, Caryn Hale, Yuhki Saito, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2212-2218
Open Access | Times Cited: 744
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 595, Iss. 7867, pp. 426-431
Open Access | Times Cited: 742
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, et al.
Science Immunology (2021) Vol. 6, Iss. 58
Open Access | Times Cited: 655
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Alison Tarke, John Sidney, Nils Methot, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100355-100355
Open Access | Times Cited: 618
Homologous and Heterologous Covid-19 Booster Vaccinations
Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 11, pp. 1046-1057
Open Access | Times Cited: 532
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 501
Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination
Mark M. Painter, Divij Mathew, Rishi R. Goel, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2133-2142.e3
Open Access | Times Cited: 426
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
Kristen W. Cohen, Susanne L. Linderman, Zoe Moodie, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 7, pp. 100354-100354
Open Access | Times Cited: 405
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 23, pp. 2201-2212
Open Access | Times Cited: 377
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Meng Yuan, Deli Huang, Chang‐Chun D. Lee, et al.
Science (2021) Vol. 373, Iss. 6556, pp. 818-823
Open Access | Times Cited: 362
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
Sandile Cele, Laurelle Jackson, David S. Khoury, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 342
Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa
Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 341
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e52-e61
Open Access | Times Cited: 340
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 278
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 274
Hybrid immunity
Shane Crotty
Science (2021) Vol. 372, Iss. 6549, pp. 1392-1393
Closed Access | Times Cited: 264
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021
Alyson M. Cavanaugh, Kevin B. Spicer, Douglas Thoroughman, et al.
MMWR Morbidity and Mortality Weekly Report (2021) Vol. 70, Iss. 32, pp. 1081-1083
Open Access | Times Cited: 243
Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine
Ofer Beharier, Romina Plitman Mayo, Tal Raz, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 227
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Carolina Lucas, Chantal B. F. Vogels, İnci Yıldırım, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 523-529
Open Access | Times Cited: 226
Page 1 - Next Page

Scroll to top